Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Long-Term Investments (2022 - 2025)

Jin Medical International's Long-Term Investments history spans 2 years, with the latest figure at $8.3 million for Q3 2023.

  • For Q3 2023, Long-Term Investments rose 70.17% year-over-year to $8.3 million; the TTM value through Sep 2023 reached $8.3 million, up 70.17%, while the annual FY2023 figure was $8.3 million, 70.17% up from the prior year.
  • Long-Term Investments for Q3 2023 was $8.3 million at Jin Medical International, up from $4.9 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $8.3 million in Q3 2023 and bottomed at $4.9 million in Q3 2022.